NCT02801409
- Conditions
- Agnosia, Anesthesia, Epidural, Lung Cancer, +18 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Thoracic Neoplasms
Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.
8,123 public trials
1,865 recruiting studies
Thoracic Neoplasms trial results
NCT03450330
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- St George Hospital Sydney, New South Wales, Australia
- Austin Hospital Heidelberg, Victoria, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
- Northern Cancer Institute St Leonards Sydney, Australia
NCT00547105
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States
NCT02499770
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Genesis Cancer Center Hot Springs, Arkansas, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- The Oncology Institute of Hope and Innovation Whittier, California, United States
- Memorial Hospital - Univ. of Colorado Health Colorado Springs, Colorado, United States
NCT00986297
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
- Locations
-
- Stanford University Stanford, California, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Completed
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
NCT01218516
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +8 more
- Locations
-
- Ironwood Cancer and Research Center Chandler, Arizona, United States
- Arizona Center for Hematology Oncology Glendale, Arizona, United States
- Providence Health System Beverly Hills, California, United States
- Cancer Care Associates of Fresno Medical Group, Inc. Fresno, California, United States
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT00006469
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Washington Cancer Institute at Washington Hospital Center Washington D.C., District of Columbia, United States
- Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center Baltimore, Maryland, United States
NCT03086733
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT02492568
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Antoni van Leeuwenhoek (NKI-AVL) Amsterdam, North Holland, Netherlands